REICHMOND LABORATORIES is promoting the construction of a new pharmaceutical biotechnology plant for the production and filling of vaccines using Ad5/Ad26 viral vectors, compatible with the production of monoclonal antibodies (mAbs).
AXIOM has drafted all the necessary projects (conceptual, basic and detailed) and has carried out the Project Management and supervision and construction management to ensure the correct execution of the new GMP pharmaceutical production plant, covering architecture and facilities (purified water, water for injection, pure steam, HVAC, compressed air, etc.).
